Why Biotech and Pharma Need GxP for their Digital Transformation Projects Now
Pharma 4.0 is here – we need to understand the compliance implications of big data and AI
With Pharma 4.0 comes a paradigm shift in many aspects. We in the pharma industry know all too well that every move we make needs to consider compliance with regulation - it's in everything that we do. Yet we can’t ignore the promise that these new technologies come with while at the same time speculating about the regulatory aspects. Although it may seem overwhelming right now, we must change the way we think. New technologies such as big data, artificial intelligence, machine learning, and deep learning offer unprecedented analysis of real-time data and can even predict trends in processes, operations, and quality. You probably have heard this many times before, but it is truer this time than before.